Table 5.

Univariate Cox regression analysis of the clinicopathological factors and DFS of breast cancer patients

Covariates	Univariate analysis
	HR (95% CI)	P value
DFS
MAP1B expression (Low vs. High)	4.175 (1.664-10.478)	0.002
JCAD expression (Low vs. High)	4.424 (1.653-11.838)	0.003
VASH1 expression (Low vs. High)	3.614 (1.500-8.711)	0.004
MGP expression (Low vs. High)	2.043 (0.895-4.664)	0.090
IGFBP5 expression (Low vs. High)	1.917 (0.841-4.373)	0.122
Age (<50 years vs.≥50 years)	4.383 (1.503-12.787)	0.007
T		0.199
T1 vs. T2	1.621 (0.517-5.084)	0.408
T1 vs. T3	2.926 (0.730-11.728)	0.130
T1 vs. T4	3.856 (0.941-15.793)	0.061
N (N0 vs. N1)	3.289 (1.121-9.653)	0.030
M (M0 vs. M1)	98.513 (12.497-776.574)	<0.001
Stage		0.001
ER (Negative vs. Positive)	0.740 (0.336-1.632)	0.456
PR (Negative vs. Positive)	0.626 (0.270-1.455)	0.276
Her-2 (Negative vs. Positive)	1.436 (0.655-3.150)	0.366
Immunohistochemical type		0.569
Luminal vs. TNBC	0.905 (0.334-2.455)	0.845
Her-2 positive vs. TNBC	1.467 (0.508-4.239)	0.478